简体中文
About Us

Yunnan Hansu Biotechnology Co.,Ltd (Hansu) one of subsidiary companies of HMI Group is a legal company on extracting of industrial hemp established in 2016 China. Hansu has built the industrial hemp plant extraction factory and scientific research base approved by Yunnan provincial government and public security department in Kunming. Hansu approved industrial hemp extraction license by Yunan province narcotics control bureau conforming to GMP (Good Manufacture Practices) standards extracting & separating CBD from industrial hemp by alcohol - soluble liquid crystallization technology, which is of positive significance to health industry. CBD has been widely used in pharmaceutical industry, food industry, health industry, beauty industry and other industries.

Hansu is the CBD extraction industry standardizer designated by GOC (the government of China) which used the raw materials all from industrial hemp cultivation bases certified by the European Union providing a strong guarantee for the consistency, safety and effectiveness of the products, with scientific and strict standard operating procedures (SOP) to control the entire production.

Hansu holds Production Safety & Product security as its production philosophy& manufacturing principles which equipped with advanced instruments in accordance with international standards professional detection of heavy metals & agricultural residues of atomic absorption spectrophotometer and monitoring the residual solvent analysis of the gas chromatograph. Hansu guarantees each gram of product through a number of testing procedures before packaging leave factory.

Hansu can extract 13 kinds of no psychoactive active ingredients from industrial hemp which is only factory can extract Cannflavin A and supplying highly competitive products to the world including CBD in different purity, 99% CBD Crystal, Water soluble CBD, full spectrum hemp oil and terpenes.

Hansu the famous CBD extraction plant base together with Yang Baofeng the president of Harbin Medical University established academician expert workstation hiring a team of internationally renowned scientists which committed to the global plant extraction field forward-looking R&D work. Hansu CBD extraction process obtained patent of United States industrial hemp extraction. Hansu devoted itself into explore and conquer cancer, Parkinson's disease, alzheimer's disease, depression, epilepsy and other disease by providing reliable raw materials and process.

Hansu is industrial hemp extraction industry standardizer and demonstration project of Yunnan drug control bureau continuous selected as“2017 Yunnan Technology-based SMEs ””2018 National Technology-based SMEs ”” 2018 Yunnan HI-tech Enterprice”as main project of “Science & Technology Entering Yunnan”

At present, Chinese A-shares listed company Galaxy Biomed (Stock Code: 000806), Hong Kong-listed company Meilleure Health International Group (Stock Code: HK02327) have been invested in Hansu with 5.55% and 20% shares respectively. The phaseⅡof the Hansu industrialization project will put into operation by the end of 2019. Its processing industrial hemp capacity can reach 2000 tons, which will become a large industrial hemp extraction & processing enterprise. Leading investment by MOST((Ministry of Science and Technology), Tsinghua Tusstar, LP and large state-owned enterprises will participate in the project as the main investors.

INDUSTRY QUALIFICATION